For Research Use Only. This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). This product is covered by one or more patents, trademarks and / or copyrights owned or controlled by Aldatu Biosciences, Inc.
PANDAA Ebola + Marburg
First universal molecular diagnostic for the simultaneous detection and differentiation of Ebolavirus and Marburg virus.
Currently underdevelopment for launch in late 2023. Questions? Email sales@aldatubio.com
- The only assay capable of detecting and differentiating Ebolavirus and Marburgvirus while ensure complete capture of all Ebolavirus species in a single reaction.
- Fast – delivers accurate results from RNA in 1 hour
- Platform-agnostic – compatible with most sample prep and qPCR platforms.
Additional information
| Kit Size | 96 reactions [30 µL] |
|---|
Overview
Kit Contents
Performance Summary
Resources
User guides and protocols